Does reducing a patient's CRP levels with statin therapy reduce their risk of recurrent cardiovascular events?
Kluft
Cornelis
C
Business Unit Biomedical Research of TNO Quality of Life, Leiden, The Netherlands. C.Kluft@pg.tno.nl